Wockhardt Usa Inc. Recall: buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-c
Wockhardt Usa Inc. Recall: buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-c is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Wockhardt Usa Inc.; Product: buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limite
| Recalling firm | Wockhardt Usa Inc. |
|---|---|
| Product | buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA, LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, NDC 64679-101-07. |
| Reason for recall | Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed. |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20140714 |
| Recall number | D-1513-2014 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →